Cargando…
The enemy within: Targeting host–parasite interaction for antileishmanial drug discovery
The state of antileishmanial chemotherapy is strongly compromised by the emergence of drug-resistant Leishmania. The evolution of drug-resistant phenotypes has been linked to the parasites’ intrinsic genome instability, with frequent gene and chromosome amplifications causing fitness gains that are...
Autores principales: | Lamotte, Suzanne, Späth, Gerald F., Rachidi, Najma, Prina, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464532/ https://www.ncbi.nlm.nih.gov/pubmed/28594938 http://dx.doi.org/10.1371/journal.pntd.0005480 |
Ejemplares similares
-
Dangerous Duplicity: The Dual Functions of Casein Kinase 1 in Parasite Biology and Host Subversion
por: Rachidi, Najma, et al.
Publicado: (2021) -
The enemy within: lipid asymmetry in intracellular parasite–host interactions
por: Fraser, Merryn, et al.
Publicado: (2023) -
Trifloxystrobin blocks the growth of Theileria parasites and is a promising drug to treat Buparvaquone resistance
por: Villares, Marie, et al.
Publicado: (2022) -
Ex Vivo Host and Parasite Response to Antileishmanial Drugs and Immunomodulators
por: Gonzalez-Fajardo, Laura, et al.
Publicado: (2015) -
Discovery of novel hit compounds with broad activity against visceral and cutaneous Leishmania species by comparative phenotypic screening
por: Lamotte, S., et al.
Publicado: (2019)